WC
ACHV icon

Wexford Capital’s Achieve Life Sciences ACHV Stock Holding History

Wexford Capital’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,500
Closed – – 77
2018
Q3 		$0 Buy
12,500
+3,100
+33% +$196K ﹤0.01% 136
2018
Q2 		$711K Buy
+9,400
New +$1.92M 0.05% 96
2015
Q4 		– Sell
-136
Closed -$669K – 64
2015
Q3 		$669K Buy
+136
New +$819K 0.13% 65

Other funds holding ACHV

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Wexford Capital's ACHV Position: Q4 2018 in Review

Wexford Capital sold out of Achieve Life Sciences (ACHV) in Q4 2018, closing a stake of 12,500 shares.

Wexford Capital first reported a position in ACHV in Q3 2015 and held it in 3 quarters. The position peaked at $711K in Q2 2018. 11 funds tracked by Wall St. Rank hold ACHV as of Q4 2018.

  • Wexford Capital reported no remaining Achieve Life Sciences position as of Q4 2018 after selling out during the quarter.
  • Wexford Capital sold 12,500 Achieve Life Sciences shares in Q4 2018.
  • Wexford Capital first reported a position in Achieve Life Sciences in Q3 2015 and held it in 3 quarters.
  • Wexford Capital's Achieve Life Sciences position peaked at $711K in Q2 2018.
  • 11 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2018.

Based on Wexford Capital's 13F filing for Q4 2018, filed 14 Feb 2019.